socalTECH
DECEMBER 15, 2020
Los Angeles-based life sciences investor Westlake Village BioPartners announced today that it has raised two new venture capital funds, worth a total of $500M, for its investments in biotech companies. The venture investor says it has now raised more than $820M in total for its investments. READ MORE>>.
Xconomy
SEPTEMBER 5, 2018
Los Angeles has long been in San Francisco’s shadow when it comes to life sciences investment. But a new venture capital firm led by industry veterans is trying to cast the City of Angels in a new light. Westlake Village BioPartners is launching today with $350 million in committed capital.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Xconomy
JANUARY 27, 2020
By month’s end, five more are anticipated to join the class of 2020 initial public offerings—and four of those are in life sciences, according to IPO research firm Renaissance Capital. Cancer drug developer Black Diamond filed IPO paperwork with regulators on Jan. 7 detailing its plans to use to the cash to finance Phase 1/2.
socalTECH
OCTOBER 4, 2010
Southern California venture totals for Q3 totaled around $1.0 billion in investments, according to the Q3 analysis of venture capital deals by socalTECH.com. Other big deals included $60M in investment in San Diego's Skinit , a developer of personalized "skins" for electronic devices, and $37.0M
socalTECH
JULY 7, 2010
Row 44 / John Guidon / Westlake Village - Guidon sold his last firm--Comcore Semiconductor--back in 1998 to National Semiconductor, for a substantial gain. Tags: entrepreneur startup venture capital investment repeat. Have we missed a repeat entrepreneur or company you think ought to be watched?
Xconomy
SEPTEMBER 7, 2018
If you’re still recovering from a Labor Day hangover or busy searching for the identity of the anonymous writer of the anti-Trump op-ed for the New York Times, you may have missed a few biomedical firsts.
Expert insights. Personalized for you.
113 
Let's personalize your content